Cancer Cell 2017-07-10

MUC-king with HIF May Rewire Pyrimidine Biosynthesis and Curb Gemcitabine Resistance in Pancreatic Cancer

Chi V. Dang

Index: 10.1016/j.ccell.2017.06.006

Full Text: HTML

Abstract

In this issue ofCancer Cell, Singh and colleagues report a role for MUC1-induced HIF expression in rewiring ribose synthesis, which drives pyridimine production as a possible resistance mechanism to gemcitabine, adding to complexity and multiple paths to resistance.